Kosin Medical Journal

Enacted on Jun 22, 2012
First revision Jul 1, 2017
Second revision Jan 1, 2022
Recently revised Sept 1, 2023

All manuscripts submitted to Kosin Medical Journal (KMJ) must include a data-sharing statement. KMJ adheres to the data sharing recommendations provided by the International Committee of Medical Journal Editors (ICMJE) (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results submitted after July 1, 2018 are required to include a data-sharing statement following the ICMJE guidelines. For detailed information on this requirement, authors can refer to the editorial titled "Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors," published in JKMS Vol. 32, No. 7:1051-1053 (http://crossmark.crossref.org/dialog/?doi=10.3346/jkms.2017.32.7.1051&domain=pdf&date_stamp=2017-06-05).

For clinical trials whose participant enrollment commenced on or after January 1, 2019, a data-sharing plan must be included in the trial's registration. Any changes to the data-sharing plan after registration should be updated in the statement submitted with the manuscript and reflected in the registry record.

Whether deidentified participant data, along with data dictionaries, will be shared. "Undecided" is not an acceptable answer.
Determine the specific data to be shared.
Indicate the availability of related documents such as study protocols and statistical analysis plans.
State the timeline for data availability and how long it will remain accessible.
Define the criteria for accessing the data, including the recipients, types of analyses, and the mechanism for sharing.

Authors conducting secondary analyses using shared data must confirm that their use complies with the agreed upon terms upon receiving the data. They must also acknowledge the source of the data using its unique, persistent identifier to give credit to the data generators and enable easy identification of studies supported by the data. Additionally, authors of secondary analyses must thoroughly explain how their work differs from previous analyses.

Acknowledgment and recognition are essential for those who generate and share clinical trial datasets. Researchers using data collected by others are encouraged to seek collaboration with the original data collectors. If collaboration is not feasible, the efforts of the data generators must still be acknowledged.

Adherence to this data-sharing policy fosters transparency, collaboration, and appropriate credit allocation in the research community.

Data sharing policy